vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and SurgePays, Inc. (SURG). Click either name above to swap in a different company.
Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $16.2M, roughly 1.5× SurgePays, Inc.). Ceribell, Inc. runs the higher net margin — -54.6% vs -85.6%, a 31.1% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
SurgePays, Inc. is a U.S.-headquartered fintech and telecommunications company focused on serving underbanked and low-income communities across the country. It offers prepaid wireless plans, reloadable debit cards, digital banking solutions, and daily consumer products through a nationwide network of independent local retail partners such as convenience stores.
CBLL vs SURG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $24.8M | $16.2M |
| Net Profit | $-13.5M | $-13.9M |
| Gross Margin | 87.3% | -14.8% |
| Operating Margin | -58.9% | -79.1% |
| Net Margin | -54.6% | -85.6% |
| Revenue YoY | — | 68.7% |
| Net Profit YoY | — | 30.0% |
| EPS (diluted) | $-0.35 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $16.2M | ||
| Q3 25 | $22.6M | $18.7M | ||
| Q2 25 | $21.2M | $11.5M | ||
| Q1 25 | $20.5M | $10.6M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $17.2M | $4.8M | ||
| Q2 24 | — | $15.1M | ||
| Q1 24 | — | $31.4M |
| Q4 25 | $-13.5M | $-13.9M | ||
| Q3 25 | $-13.5M | $-7.5M | ||
| Q2 25 | $-13.6M | $-7.1M | ||
| Q1 25 | $-12.8M | $-7.6M | ||
| Q4 24 | — | $-19.8M | ||
| Q3 24 | $-10.4M | $-14.3M | ||
| Q2 24 | — | $-12.9M | ||
| Q1 24 | — | $1.2M |
| Q4 25 | 87.3% | -14.8% | ||
| Q3 25 | 88.3% | -13.9% | ||
| Q2 25 | 88.1% | -23.0% | ||
| Q1 25 | 87.9% | -27.8% | ||
| Q4 24 | — | -117.0% | ||
| Q3 24 | 87.3% | -164.2% | ||
| Q2 24 | — | -22.8% | ||
| Q1 24 | — | 26.0% |
| Q4 25 | -58.9% | -79.1% | ||
| Q3 25 | -64.8% | -37.2% | ||
| Q2 25 | -70.5% | -59.1% | ||
| Q1 25 | -69.3% | -71.7% | ||
| Q4 24 | — | -209.0% | ||
| Q3 24 | -57.8% | -299.4% | ||
| Q2 24 | — | -72.1% | ||
| Q1 24 | — | 5.6% |
| Q4 25 | -54.6% | -85.6% | ||
| Q3 25 | -59.6% | -40.1% | ||
| Q2 25 | -64.4% | -61.5% | ||
| Q1 25 | -62.4% | -72.2% | ||
| Q4 24 | — | -206.5% | ||
| Q3 24 | -60.6% | -299.3% | ||
| Q2 24 | — | -85.3% | ||
| Q1 24 | — | 3.9% |
| Q4 25 | $-0.35 | $-0.68 | ||
| Q3 25 | $-0.37 | $-0.38 | ||
| Q2 25 | $-0.38 | $-0.36 | ||
| Q1 25 | $-0.36 | $-0.38 | ||
| Q4 24 | — | $-1.07 | ||
| Q3 24 | $-1.85 | $-0.73 | ||
| Q2 24 | — | $-0.66 | ||
| Q1 24 | — | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $1.7M |
| Total DebtLower is stronger | — | $13.3M |
| Stockholders' EquityBook value | $155.3M | $-15.3M |
| Total Assets | $195.8M | $8.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $1.7M | ||
| Q3 25 | $168.5M | $2.5M | ||
| Q2 25 | $177.4M | $4.4M | ||
| Q1 25 | $182.7M | $5.4M | ||
| Q4 24 | — | $11.8M | ||
| Q3 24 | $14.1M | $23.7M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $13.3M | ||
| Q3 25 | — | $12.0M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.4M | ||
| Q2 24 | — | $4.8M | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $155.3M | $-15.3M | ||
| Q3 25 | $164.1M | $-6.4M | ||
| Q2 25 | $172.2M | $116.1K | ||
| Q1 25 | $180.9M | $7.8M | ||
| Q4 24 | — | $15.3M | ||
| Q3 24 | $-136.0M | $33.2M | ||
| Q2 24 | — | $46.2M | ||
| Q1 24 | — | $56.0M |
| Q4 25 | $195.8M | $8.5M | ||
| Q3 25 | $199.5M | $14.5M | ||
| Q2 25 | $207.7M | $15.2M | ||
| Q1 25 | $213.5M | $15.7M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | $47.1M | $41.5M | ||
| Q2 24 | — | $56.4M | ||
| Q1 24 | — | $69.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 82.67× | ||
| Q1 25 | — | 0.46× | ||
| Q4 24 | — | 0.26× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $-3.6M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $-3.6M | ||
| Q3 25 | $-11.1M | $-4.6M | ||
| Q2 25 | $-7.5M | $-6.1M | ||
| Q1 25 | $-11.4M | $-7.0M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $-13.3M | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | $4.0M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 3.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
SURG
Segment breakdown not available.
